Category: Gaucher's
Global Gaucher's
-
Gaucher Disease Treatment
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion ... Read More
-
Gaucher Disease - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. ... Read More
-
Global Gaucher Disease Drugs Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Gaucher Disease Drugs industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Gaucher Disease Drugs. The report also introduces players ... Read More
-
Global Gaucher Disease (GD) Drugs Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Gaucher Disease (GD) Drugs is forecast to a readjusted size of US$ 1485.2 million by 2030 with a CAGR of 3.3% during review period. The research report highlights ... Read More
-
Enzyme Replacement Therapy Market Size, Trends, Analysis, and Outlook By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), by Region, Country, Segment, and Companies, 2024-2030 The global Enzyme Replacement Therapy market size is poised to register 6.84% growth from 2024 to 2030, presenting significant ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Enzyme Replacement Therapy for Gaucher Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Gauchier Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Type I Segment in Gaucher Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Gaucher Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Gaucher Disease Industry Research Report 2024
... global Gaucher Disease market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030. Global Gaucher Disease key players include Sanofi, ... Read More
-
Gaucher’s Disease Global Market Report 2024
... By Therapy: Enzyme Replacement Therapy; Substrate Reduction Therapy4) By Route Of Administration: Oral; Parenteral5) By End User: Hospitals; Specialty Clinics; HomecareCovering: Pfizer Inc.; Johnson & Johnson; Merck and Co. Inc.; Novartis AG; Sanofi S.A. Gaucher’s ... Read More
-
Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Global Forecast 2024-2030
... at USD 8.09 billion in 2023 and expected to reach USD 8.87 billion in 2024, at a CAGR 9.80% to reach USD 15.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Gaucher Disease Treatment Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3), Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy), Diagnosis, Distribution Channel - Global Forecast 2024-2030
... Treatment Market size was estimated at USD 1.26 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 5.18% to reach USD 1.80 billion by 2030. FPNV Positioning Matrix The ... Read More
-
Global Gaucher Disease Market Research Report 2024(Status and Outlook)
... among affected individuals. The Global Gaucher Disease Market Size was estimated at USD 1324.80 million in 2023 and is projected to reach USD 2185.38 million by 2029, exhibiting a CAGR of 8.70% during the forecast ... Read More
-
Gaucher Disease Drugs Market Size, Share & Trends Analysis Report By Type (Type 1, Type 2, Type 3, Others) By Therapy (Enzyme Replacement Therapy, Substrate Replacement Therapy, Others), By Region, And Segment Forecasts, 2023 - 2030
... 2030 Gaucher Disease Drugs Market Growth & Trends The global gaucher disease drugs market size is expected to reach USD 2.03 billion by 2030, expanding at a CAGR of 2.6% from 2023 to 2030, according ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
... Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) ... Read More
-
Enzyme Replacement Therapy Market Size - By Enzyme (Alglucosidase alfa, Agalsidase beta, Imiglucerase), Indication (Gaucher, MPS, Pompe, SCID, Fabry), Route of Administration, End-user, Global Forecast 2023-2032
... over 7% CAGR from 2023 to 2032, driven by the broader acceptance of biologics and standard treatments for various genetic disorders. Biologics, including enzyme replacement therapy (ERT) are gaining prominence as advanced and targeted treatments ... Read More
-
Gaucher Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
... markets. The global gaucher disease market is expected to reach an estimated $2.0 billion by 2030 with a CAGR of 2.1% from 2024 to 2030. The major drivers for this market are the increasing prevalence ... Read More
-
Global Pompe Disease Therapeutics Market - 2023-2030
... The global Pompe disease therapeutics market is expected to exhibit a CAGR of 4.3% during the forecast period (2023-2030). Pompe disease is an inherited lysosomal condition induced by a lack of the enzyme acid alpha-glucosidase ... Read More
-
Global Gaucher’s Disease Treatment Market Growth 2023-2029
... at a CAGR of 3.7% from 2023 to 2029. United States market for Gaucher’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
Research Assistance
